abstract |
The invention relates to novel compounds of formula (I), wherein: D, E, Q, T, X, Y, Z, Z', R<1>, R<4>, and R<4'> have the meanings cited in Claim 1. These novel compounds are inhibitors of coagulation factor Xa and can be used for the prophylaxis and/or the treatment of thromboembolic diseases and for treating tumors. |